{ "story_id": "e4735e6a117e66d28b43e4a5b4d28e5d", "desk": "drm3", "revision": 1, "published_at": "2026-09-02T10:25:02.000Z", "content_hash": "e12405f07fa4ce54a7c1ab17edb8766eb341b2a4b3ed8f3413f271c2c1191261", "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs", "basis": { "headline": "SEC Proposes First Transfer Agent Overhaul in 40 Years Amid Tokenization", "dek": "The SEC proposed updating transfer agent rules to address blockchain recordkeeping and tokenized securities.", "prose": "The Securities and Exchange Commission proposed the first substantive update to its transfer agent rules since the early 1980s on Tuesday. [^1]\n\nThe U.S. Securities and Exchange Commission (SEC) and the U.S. Food and Drug Administration (FDA) announced on 2026-08-31 that they entered into a Memorandum of Understanding (MOU) to enhance cooperation in regulatory and enforcement responsibilities. [^2]\n\nCommissioner Hester Peirce said the proposal was more than a decade in the making and invited comment on its implications for tokenization. [^3]\n\nProposed additions to Form TA-2 would require agents to report how many issues have their master securityholder file on a distributed ledger. [^4]\n\nThe proposed rules require transfer agents to disclose issues recorded on distributed ledgers and to break out tokenized issues by model. [^5]\n\nActing FDA Commissioner Kyle Diamantras J.D. said that streamlining information-sharing with the SEC helps protect patients who rely on FDA-regulated products and the public trust that drives healthcare innovation. [^6]\n\nSEC Chairman Paul S. Atkins said that FDA-related disclosures by public companies have a significant impact on the markets and that the FDA is a valuable partner in administering and enforcing disclosure requirements under federal securities laws. [^7]\n\nThe MOU establishes a framework for information-sharing protocols to facilitate the exchange of information between the SEC and FDA that is relevant to both agencies' missions. [^8]", "cited": "[{\"statement\":\"The Securities and Exchange Commission proposed the first substantive update to its transfer agent rules since the early 1980s on Tuesday.\",\"source\":\"Decrypt\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T10:25:02.000Z\",\"publisher_count\":1,\"sources\":[\"Decrypt\"]},{\"statement\":\"The U.S. Securities and Exchange Commission (SEC) and the U.S. Food and Drug Administration (FDA) announced on 2026-08-31 that they entered into a Memorandum of Understanding (MOU) to enhance cooperation in regulatory and enforcement responsibilities.\",\"source\":\"U.S. Securities and Exchange Commission\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-08-31T18:24:32.000Z\",\"publisher_count\":1,\"sources\":[\"U.S. Securities and Exchange Commission\"]},{\"statement\":\"Commissioner Hester Peirce said the proposal was more than a decade in the making and invited comment on its implications for tokenization.\",\"source\":\"Decrypt\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T10:25:02.000Z\",\"publisher_count\":1,\"sources\":[\"Decrypt\"]},{\"statement\":\"Proposed additions to Form TA-2 would require agents to report how many issues have their master securityholder file on a distributed ledger.\",\"source\":\"Decrypt\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T10:25:02.000Z\",\"publisher_count\":1,\"sources\":[\"Decrypt\"]},{\"statement\":\"The proposed rules require transfer agents to disclose issues recorded on distributed ledgers and to break out tokenized issues by model.\",\"source\":\"Decrypt\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T10:25:02.000Z\",\"publisher_count\":1,\"sources\":[\"Decrypt\"]},{\"statement\":\"Acting FDA Commissioner Kyle Diamantras J.D. said that streamlining information-sharing with the SEC helps protect patients who rely on FDA-regulated products and the public trust that drives healthcare innovation.\",\"source\":\"U.S. Securities and Exchange Commission\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-08-31T18:24:32.000Z\",\"publisher_count\":1,\"sources\":[\"U.S. Securities and Exchange Commission\"]},{\"statement\":\"SEC Chairman Paul S. Atkins said that FDA-related disclosures by public companies have a significant impact on the markets and that the FDA is a valuable partner in administering and enforcing disclosure requirements under federal securities laws.\",\"source\":\"U.S. Securities and Exchange Commission\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-08-31T18:24:32.000Z\",\"publisher_count\":1,\"sources\":[\"U.S. Securities and Exchange Commission\"]},{\"statement\":\"The MOU establishes a framework for information-sharing protocols to facilitate the exchange of information between the SEC and FDA that is relevant to both agencies' missions.\",\"source\":\"U.S. Securities and Exchange Commission\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-08-31T18:24:32.000Z\",\"publisher_count\":1,\"sources\":[\"U.S. Securities and Exchange Commission\"]}]", "kind": "news" }, "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature", "receipt": null, "receipt_note": "this revision predates receipt-keeping (before v0.37.0); the filed row lives in the record", "generation_chain": { "wire": { "stream": "fountain_news", "story_id": "dd6e2b45191e0fa14ec7651d39854f7f", "thread_id": "45a8e375f0b33da0da18e4d9c76a2930", "thread_label": "Paul S. Atkins", "novelty": "UPDATE", "content_hash": "9a4b0f798cd621fdd9ee29f52648b3b2efc08ab12119320eff7048f7a6b2cfe0", "last_published_at": "2026-09-02T10:25:02.000Z", "read_receipt": { "slice_hash": "6f69d013059537a87af2b87c922b212011d4fe7ee12036f9066de5c4cc30281c", "cursor_from": "eyJ0cyI6IjIwMjYtMDktMDJUMDk6NTM6MDUuMDAwMDAwWiIsImlkIjoiNTA2NzViODllMmUyZDU3ZGJhMzQzOWRiYTFlYmRkYmYiLCJ2IjoiMSJ9", "cursor_to": "eyJ0cyI6IjIwMjYtMDktMDJUMTE6MDA6MjIuMDAwMDAwWiIsImlkIjoiM2RkNTFiYjNlY2NkMTFkMzc0ZmJjN2UyNWU0OTBhOWYiLCJ2IjoiMSJ9", "view": "v_fountain_news", "view_version": "1", "row_count": 100, "window_days": 3, "bytes_scanned": 12017721, "credits": 8, "price_per_100_rows": 8, "sig": "y-CC-1scxAEM_nQQodB8JAFq-dwPb14ApmlmnG93xGLLF_uL8rplYgVGN6oy6mZzw1MUve5kLVLnYlxMxRVBDA", "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE", "signer_path": "lakehouse/data-extract/v1", "alg": "Ed25519", "signed": true } }, "written_at": "2026-09-02T22:46:22.065Z" }, "cited_facts": [ { "statement": "The Securities and Exchange Commission proposed the first substantive update to its transfer agent rules since the early 1980s on Tuesday.", "source": "Decrypt", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T10:25:02.000Z", "publisher_count": 1, "sources": [ "Decrypt" ] }, { "statement": "The U.S. Securities and Exchange Commission (SEC) and the U.S. Food and Drug Administration (FDA) announced on 2026-08-31 that they entered into a Memorandum of Understanding (MOU) to enhance cooperation in regulatory and enforcement responsibilities.", "source": "U.S. Securities and Exchange Commission", "instrument": "News", "claim_key": null, "published_at": "2026-08-31T18:24:32.000Z", "publisher_count": 1, "sources": [ "U.S. Securities and Exchange Commission" ] }, { "statement": "Commissioner Hester Peirce said the proposal was more than a decade in the making and invited comment on its implications for tokenization.", "source": "Decrypt", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T10:25:02.000Z", "publisher_count": 1, "sources": [ "Decrypt" ] }, { "statement": "Proposed additions to Form TA-2 would require agents to report how many issues have their master securityholder file on a distributed ledger.", "source": "Decrypt", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T10:25:02.000Z", "publisher_count": 1, "sources": [ "Decrypt" ] }, { "statement": "The proposed rules require transfer agents to disclose issues recorded on distributed ledgers and to break out tokenized issues by model.", "source": "Decrypt", "instrument": "News", "claim_key": null, "published_at": "2026-09-02T10:25:02.000Z", "publisher_count": 1, "sources": [ "Decrypt" ] }, { "statement": "Acting FDA Commissioner Kyle Diamantras J.D. said that streamlining information-sharing with the SEC helps protect patients who rely on FDA-regulated products and the public trust that drives healthcare innovation.", "source": "U.S. Securities and Exchange Commission", "instrument": "News", "claim_key": null, "published_at": "2026-08-31T18:24:32.000Z", "publisher_count": 1, "sources": [ "U.S. Securities and Exchange Commission" ] }, { "statement": "SEC Chairman Paul S. Atkins said that FDA-related disclosures by public companies have a significant impact on the markets and that the FDA is a valuable partner in administering and enforcing disclosure requirements under federal securities laws.", "source": "U.S. Securities and Exchange Commission", "instrument": "News", "claim_key": null, "published_at": "2026-08-31T18:24:32.000Z", "publisher_count": 1, "sources": [ "U.S. Securities and Exchange Commission" ] }, { "statement": "The MOU establishes a framework for information-sharing protocols to facilitate the exchange of information between the SEC and FDA that is relevant to both agencies' missions.", "source": "U.S. Securities and Exchange Commission", "instrument": "News", "claim_key": null, "published_at": "2026-08-31T18:24:32.000Z", "publisher_count": 1, "sources": [ "U.S. Securities and Exchange Commission" ] } ], "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true." }